Page last updated: 2024-10-21

2-aminoethoxydiphenyl borate and Renal Insufficiency, Chronic

2-aminoethoxydiphenyl borate has been researched along with Renal Insufficiency, Chronic in 1 studies

2-aminoethoxydiphenyl borate: is a novel membrane-penetrable modulator and transient receptor potential channel blocker; structure in first source; do not confuse with 2-APB cpd
2-aminoethoxydiphenylborane : An organoboron compound that is diphenylborane in which the borane hydrogen is replaced by a 2-aminoethoxy group.

Renal Insufficiency, Chronic: Conditions in which the KIDNEYS perform below the normal level for more than three months. Chronic kidney insufficiency is classified by five stages according to the decline in GLOMERULAR FILTRATION RATE and the degree of kidney damage (as measured by the level of PROTEINURIA). The most severe form is the end-stage renal disease (CHRONIC KIDNEY FAILURE). (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Krieger, NS1
Bushinsky, DA1

Other Studies

1 other study available for 2-aminoethoxydiphenyl borate and Renal Insufficiency, Chronic

ArticleYear
Stimulation of fibroblast growth factor 23 by metabolic acidosis requires osteoblastic intracellular calcium signaling and prostaglandin synthesis.
    American journal of physiology. Renal physiology, 2017, Oct-01, Volume: 313, Issue:4

    Topics: Acidosis; Animals; Bone Resorption; Boron Compounds; Calcium Signaling; Fibroblast Growth Factor-23;

2017